lansoprazole has been researched along with Arrhythmia in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Excerpt | Relevance | Reference |
---|---|---|
"To compare lansoprazole with another proton pump inhibitor (PPI) during ceftriaxone treatment in terms of risk for ventricular arrhythmia, cardiac arrest, and in-hospital mortality." | 8.31 | Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole. ( Almufleh, A; Bai, AD; Rai, M; Razak, F; Srivastava, S; Verma, AA; Wilkinson, A, 2023) |
"To compare lansoprazole with another proton pump inhibitor (PPI) during ceftriaxone treatment in terms of risk for ventricular arrhythmia, cardiac arrest, and in-hospital mortality." | 4.31 | Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole. ( Almufleh, A; Bai, AD; Rai, M; Razak, F; Srivastava, S; Verma, AA; Wilkinson, A, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bai, AD | 1 |
Wilkinson, A | 1 |
Almufleh, A | 1 |
Rai, M | 1 |
Razak, F | 1 |
Verma, AA | 1 |
Srivastava, S | 1 |
Wolfes, J | 1 |
Ellermann, C | 1 |
Burde, S | 1 |
Leitz, P | 1 |
Bögeholz, N | 1 |
Willy, K | 1 |
Fehr, M | 1 |
Eckardt, L | 1 |
Frommeyer, G | 1 |
2 other studies available for lansoprazole and Arrhythmia
Article | Year |
---|---|
Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole.
Topics: Adult; Aged; Arrhythmias, Cardiac; Ceftriaxone; Cohort Studies; Female; Heart Arrest; Humans; Inpati | 2023 |
Concomitant Treatment with Proton Pump Inhibitors and Cephalosporins Does Not Enhance QT-Associated Proarrhythmia in Isolated Rabbit Hearts.
Topics: Action Potentials; Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; | 2020 |